Terms: = Cervical cancer AND NTRK1, ENSG00000198400, 4914, P04629, TRK1, MTC, DKFZp781I14186, p140-TrkA, TRKA, TRK AND Treatment
53 results:
1. Combining radiomics with thyroid imaging reporting and data system to predict lateral cervical lymph node metastases in medullary thyroid cancer.
Liu Z; Zhang X; Zhao X; Guo Q; Li Z; Wei M; Niu L; An C
BMC Med Imaging; 2024 Mar; 24(1):64. PubMed ID: 38500053
[TBL] [Abstract] [Full Text] [Related]
2. Ntrk-rearranged spindle cell sarcoma of the uterine cervix with a novel NUMA1::ntrk1 fusion.
Szalai L; Vereczkey I; Szemes M; Rókusz A; Csernák E; Tóth E; Melegh Z
Virchows Arch; 2024 Mar; 484(3):527-531. PubMed ID: 38151535
[TBL] [Abstract] [Full Text] [Related]
3. Risk factors for cervical lymph node metastasis in the central or lateral cervical region in medullary thyroid carcinoma: a systematic review and meta-analysis.
Lin X; Huo J; Su H; Zhu C; Xu Y; Zhang F
Eur Arch Otorhinolaryngol; 2024 Feb; 281(2):547-561. PubMed ID: 37801162
[TBL] [Abstract] [Full Text] [Related]
4. Clinical Evolution of Sporadic Medullary Thyroid Carcinoma With Biochemical Incomplete Response After Initial treatment.
Prete A; Gambale C; Torregrossa L; Ciampi R; Romei C; Ramone T; Agate L; Bottici V; Cappagli V; Molinaro E; Materazzi G; Elisei R; Matrone A
J Clin Endocrinol Metab; 2023 Jul; 108(8):e613-e622. PubMed ID: 36722192
[TBL] [Abstract] [Full Text] [Related]
5. Mixed response and mechanisms of resistance to larotrectinib in metastatic carcinoma ex pleomorphic adenoma of the parotid harboring an Ntrk2 fusion: A case report.
Pircher M; Briner HR; Bonomo M; Horcic M; Petrausch U; Helbling D; Winder T
Medicine (Baltimore); 2021 Jan; 100(4):e24463. PubMed ID: 33530256
[TBL] [Abstract] [Full Text] [Related]
6. Positron Emission Tomography Imaging in Medullary Thyroid Carcinoma: Time for Reappraisal?
Castinetti F; Taïeb D
Thyroid; 2021 Feb; 31(2):151-155. PubMed ID: 33191866
[TBL] [Abstract] [Full Text] [Related]
7. Rapid, complete and sustained tumour response to the trk inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-Ntrk3 gene fusion.
Bielack SS; Cox MC; Nathrath M; Apel K; Blattmann C; Holl T; Jenewein R; Klenk U; Klothaki P; Müller-Abt P; Ortega-Lawerenz S; Reynolds M; Scheer M; Simon-Klingenstein K; Stegmaier S; Tupper R; Vokuhl C; von Kalle T
Ann Oncol; 2019 Nov; 30 Suppl 8():viii31-viii35. PubMed ID: 32223937
[TBL] [Abstract] [Full Text] [Related]
8. Rapid, complete and sustained tumour response to the trk inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-Ntrk3 gene fusion.
Bielack SS; Cox MC; Nathrath M; Apel K; Blattmann C; Holl T; Jenewein R; Klenk U; Klothaki P; Müller-Abt P; Ortega-Lawerenz S; Reynolds M; Scheer M; Simon-Klingenstein K; Stegmaier S; Tupper R; Vokuhl C; von Kalle T
Ann Oncol; 2019 Nov; 30(Suppl_8):viii31-viii35. PubMed ID: 31738425
[TBL] [Abstract] [Full Text] [Related]
9. RET Proto-oncogene Gene Mutation Is Related to cervical Lymph Node Metastasis in Medullary Thyroid Carcinoma.
Wang S; Wang B; Xie C; Ye D
Endocr Pathol; 2019 Dec; 30(4):297-304. PubMed ID: 31494787
[TBL] [Abstract] [Full Text] [Related]
10. Ultrasound-guided laser ablation for local control of neck recurrences of medullary thyroid cancer. A feasibility study.
Persichetti A; Bizzarri G; Guglielmi R; Barnabei A; Bianchini A; Coccaro C; Appetecchia M; Papini E
Int J Hyperthermia; 2018; 35(1):480-492. PubMed ID: 30204004
[TBL] [Abstract] [Full Text] [Related]
11. Temporal Trends in the Presentation, treatment, and Outcome of Medullary Thyroid Carcinoma: An Israeli Multicenter Study.
Hirsch D; Twito O; Levy S; Bachar G; Robenshtok E; Gross DJ; Mazeh H; Benbassat C; Grozinsky-Glasberg S
Thyroid; 2018 Mar; 28(3):369-376. PubMed ID: 29402183
[TBL] [Abstract] [Full Text] [Related]
12. PROGNOSTIC VARIABLES AFFECTING PRIMARY treatment OUTCOME FOR MEDULLARY THYROID cancer.
Momin S; Chute D; Burkey B; Scharpf J
Endocr Pract; 2017 Sep; 23(9):1053-1058. PubMed ID: 28683235
[TBL] [Abstract] [Full Text] [Related]
13. Metastatic lymph node ratio can further stratify risk for mortality in medullary thyroid cancer patients: A population-based analysis.
Qu N; Shi RL; Lu ZW; Liao T; Wen D; Sun GH; Li DS; Ji QH
Oncotarget; 2016 Oct; 7(40):65937-65945. PubMed ID: 27588396
[TBL] [Abstract] [Full Text] [Related]
14. Late liver metastasis of medullary thyroid cancer with low calcitonin levels - successfully cured by radiofrequency.
Al-Salameh A; Baudry C; Gautier JF; Toubert ME; Bihan H; Cohen R
Endokrynol Pol; 2016; 67(3):326-9. PubMed ID: 26884307
[TBL] [Abstract] [Full Text] [Related]
15. Surgery for lymph node metastases of medullary thyroid carcinoma: A review.
Jin LX; Moley JF
Cancer; 2016 Feb; 122(3):358-66. PubMed ID: 26539937
[TBL] [Abstract] [Full Text] [Related]
16. Incidental thyroid C cell hyperplasia: clinical significance and implications in practice.
Sakorafas GH; Nasikas D; Thanos D; Gantzoulas S
Oncol Res Treat; 2015; 38(5):249-52. PubMed ID: 25966772
[TBL] [Abstract] [Full Text] [Related]
17. Synchronous occurrence of medullary and papillary carcinoma of the thyroid in a patient with cutaneous melanoma: determination of BRAFV600E in peripheral blood and tissues. Report of a case and review of the literature.
Fibbi B; Pinzani P; Salvianti F; Rossi M; Petrone L; De Feo ML; Panconesi R; Vezzosi V; Bianchi S; Simontacchi G; Mangoni M; Pertici M; Forti G; Pupilli C
Endocr Pathol; 2014 Sep; 25(3):324-31. PubMed ID: 24858900
[TBL] [Abstract] [Full Text] [Related]
18. [Medullary thyroid carcinoma in children].
Berdelou A; Hartl D; Al Ghuzlan A; Mirghani H; Chougnet C; Baudin E; Schlumberger M; Leboulleux S
Bull Cancer; 2013; 100(7-8):780-8. PubMed ID: 23831771
[TBL] [Abstract] [Full Text] [Related]
19. Medullary thyroid cancer--current treatment strategy, novel therapies and perspectives for the future.
Sugawara M; Ly T; Hershman JM
Horm Cancer; 2012 Dec; 3(5-6):218-26. PubMed ID: 23011723
[TBL] [Abstract] [Full Text] [Related]
20. Medullary thyroid carcinoma surgical cytoreduction induces an increase in serum calcitonin and carcinoembryonic antigen doubling times.
Papapetrou PD; Polymeris A
Exp Clin Endocrinol Diabetes; 2012 Mar; 120(3):164-8. PubMed ID: 22328112
[TBL] [Abstract] [Full Text] [Related]
[Next]